Publications by authors named "Jerry Tolson"

Claim this Profile
A
A Phase I, Open-Label, Dose-Finding Study of GSK2636771, a PI3Kβ Inhibitor, Administered with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer.
Debashis Sarker, Nancy A Dawson, Ana M Aparicio, Tanya B Dorff, Allan J Pantuck, Jerry Tolson

Clin Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours.
Gabriel Mak, Jean-Charles Soria, Sarah P Blagden, Ruth Plummer, Ronald A Fleming, Jerry Tolson

Br J Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author response: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
Amit Bar-Or, Richard A Grove, Jerry M Tolson, Frederick J Derosier, Monica C Lopez

Neurology· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098.
Nicholas F Brown, Matthew Williams, Hendrik-Tobias Arkenau, Ronald A Fleming, Jerry Tolson

Neuro Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
Amit Bar-Or, Richard A Grove, Daren J Austin, Jerry M Tolson, Susan A VanMeter

Neurology· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors.
Joaquin Mateo, Gopinath Ganji, Charlotte Lemech, Howard A Burris, Sae-Won Han, Jerry M Tolson

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 52-week study of gabapentin enacarbil in restless legs syndrome.
Aaron L Ellenbogen, Stephen G Thein, David H Winslow, Philip M Becker, Jerry M Tolson

Clin Neuropharmacol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient- and physician-rated measures demonstrate the effectiveness of ropinirole in the treatment of restless legs syndrome.
Clete A Kushida, James Geyer, Jerry M Tolson, Afsaneh Asgharian

Clin Neuropharmacol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recognition, diagnosis, and treatment of restless legs syndrome.
Jennifer E Smith, Jerry M Tolson

J Am Acad Nurse Pract· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV antiretroviral treatment: early versus later.
Josephine Mauskopf, Mari Kitahata, Teresa Kauf, Anke Richter, Jerry Tolson

J Acquir Immune Defic Syndr· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.
Valerie E Stone, Jamie Jordan, Jerry Tolson, Robert Miller, Tom Pilon

J Acquir Immune Defic Syndr· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of an educational program on efficacy and adherence with a twice-daily lamivudine/zidovudine/abacavir regimen in underrepresented HIV-infected patients.
M Keith Rawlings, Melanie A Thompson, Charles F Farthing, Lawrence S Brown, Joseph Racine, Jerry M Tolson

J Acquir Immune Defic Syndr· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily quadruple-drug therapy with adefovir dipivoxil, Lamivudine, Didanosine, and efavirenz in treatment-naive human immunodeficiency virus type 1-infected patients.
Gail Skowron, Daniel R Kuritzkes, Melanie A Thompson, Kathleen E Squires, S Diane Goodwin, Jerry M Tolson

J Infect Dis· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic and virologic consequences of temporary antiretroviral treatment interruption in clinical practice.
Ray Y Chen, Andrew O Westfall, James L Raper, Gretchen A Cloud, Ashlee K Chatham, Jerry M Tolson

AIDS Res Hum Retroviruses· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis